NCT01069575 2019-03-19
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer
Shiga University
Phase 1 Completed
Clinical Trials
3 trialsNCT01069640 2019-03-19
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer
Shiga University
Phase 1 Completed
NCT00674258 2008-05-14
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
Tokyo University
Phase 1/2 Unknown